Fludarabine phosphate: a new active agent in hematologic malignancies
Keating, M.J.; O'Brien, S.; Plunkett, W.; Robertson, L.E.; Gandhi, V.; Estey, E.; Dimopoulos, M.; Cabanillas, F.; Kemena, A.; Kantarjian, H.
Seminars in Hematology 31(1): 28-39
1994
ISSN/ISBN: 0037-1963 PMID: 7510070 Document Number: 432836
Document emailed within 1 workday
Related Documents
Abang, A.M.; Abbas, S.A.; Pham, T.; Lambros, M.P. 2001: A new High-performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes International Journal of Pharmaceutical Compounding 5(4): 320-322Usui, N. 2019: Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 859-861
Murakami, H.; Saitoh, T.; Kasamatsu, T. 2016: Hematologic Malignancies/Pediatric Malignancies. III. Treatment of Relapsed/Refractory Multiple Myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(5): 539-544
Usui, N. 2017: Hematologic Malignancies/Pediatric Malignancies Acute Leukemia - Current Treatment and Future Perspective Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(5): 378-379
Usui, N. 2011: Hematologic malignancies/ pediatric malignancies-chronic myeloid leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(5): 744
Usui, N. 2009: Hematologic malignancies/pediatric malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 742-743
Chun, H.G.; Leyland-Jones, B.R.; Caryk, S.M.; Hoth, D.F. 1986: Central nervous system toxicity of fludarabine phosphate Cancer Treatment Reports 70(10): 1225-1228
Grever, M.R.; Kopecky, K.J.; Coltman, C.A.; Files, J.C.; Greenberg, B.R.; Hutton, J.J.; Talley, R.; Von Hoff, D.D.; Balcerzak, S.P. 1988: Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia Nouvelle Revue Francaise d'Hematologie 30(5-6): 457-459
Goodman, E.R.; Fiedor, P.S.; Fein, S.; Sung, R.S.; Athan, E.; Hardy, M.A. 1995: Fludarabine phosphate and 2-chlorodeoxyadenosine: immunosuppressive DNA synthesis inhibitors with potential application in islet allo- and xenotransplantation Transplantation Proceedings 27(6): 3293-3294
Weiss, G.B.; Metch, B.; Von Hoff, D.D.; Taylor, S.A.; Saiers, J.H. 1987: Phase Ii trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study Cancer Treatment Reports 71(12): 1313-1314
Nara, N. 2002: Molecular diagnosis in hematologic malignancies Rinsho Byori. Japanese Journal of Clinical Pathology 50(4): 331-336
Baltz, J.K.; Montello, M.J. 1993: Cladribine for the treatment of hematologic malignancies Clinical Pharmacy 12(11): 805
Wierda, W.G.; Kipps, T.J. 2000: Gene therapy of hematologic malignancies Seminars in Oncology 27(5): 502-511
San-Miguel, J.F.; Bartram, C.; Campana, D.; Andreeff, M. 1994: Minimal residual disease in hematologic malignancies Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion Suppl: 147-152
Gutterman, J.U. 1988: The role of interferons in the treatment of hematologic malignancies Seminars in Hematology 25(3 Suppl 3: 3-8
Ueoka, H.; Ueno, K.; Yamane, T.; Toyoda, K.; Endo, H.; Nishihara, R.; Takahashi, I.; Ohnoshi, T.; Kitajima, K.; Kimura, I. 1983: Phase Ii study of mitoxantrone for hematologic malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 10(11): 2399-2402
Hernández, J.A.; Martino, R.; Pericas, R.; Sureda, A.; Brunet, S.; Domingo-Albós, A. 1998: Achromobacter xylosoxidans bacteremia in patients with hematologic malignancies Haematologica 83(3): 284-285
Curtis, M.A. 2003: New monoclonal antibodies for hematologic malignancies (and breast cancer) Medicine and Health Rhode Island 86(8): 256-257
Garewal, H.; Durie, B.G. 1981: Beta 2-microglobulin: a potentially useful marker for hematologic malignancies Arizona Medicine 38(12): 912-913
deMagalhaes-Silverman, M.; Bloom, E.J.; Donnenberg, A.; Lister, J.; Pincus, S.; Rybka, W.B.; Ball, E.D. 1996: Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies Bone Marrow Transplantation 17(3): 329-333